Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,235,145
-
Total 13F shares
-
71,721,890
-
Share change
-
+630,781
-
Total reported value
-
$2,885,022,540
-
Put/Call ratio
-
34%
-
Price per share
-
$40.23
-
Number of holders
-
177
-
Value change
-
+$14,409,751
-
Number of buys
-
79
-
Number of sells
-
88
Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q4 2024
As of 31 Dec 2024,
Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by
177 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,721,890 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, Avoro Capital Advisors LLC, Atlas Venture Life Science Advisors, LLC, VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., and Siren, L.L.C..
This page lists
177
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.